title: Infectious disease. Combating emerging viral threats.
authors.affiliation: Department of Medicine, Division of Infectious Diseases and Geographic Medicine, and Department of Microbiology and Immunology, Stanford University School of Medicine, Stanford, CA, USA.
authors.forename: Elena
authors.initials: E
authors.lastname: Bekerman
authors.affiliation: Department of Medicine, Division of Infectious Diseases and Geographic Medicine, and Department of Microbiology and Immunology, Stanford University School of Medicine, Stanford, CA, USA. seinav@stanford.edu.
authors.forename: Shirit
authors.initials: S
authors.lastname: Einav
mesh_terms: D000225:Adenine / Q000031:analogs & derivatives; D000241:Adenosine / Q000031:analogs & derivatives; D000998:Antiviral Agents / Q000191:economics / Q000494:pharmacology / Q000627:therapeutic use*; D001549:Benzamides / Q000191:economics / Q000494:pharmacology / Q000627:therapeutic use; D002738:Chloroquine / Q000191:economics / Q000494:pharmacology / Q000627:therapeutic use; D021821:Communicable Diseases, Emerging / Q000188:drug therapy* / Q000821:virology*; D003524:Cyclosporins / Q000191:economics / Q000494:pharmacology / Q000627:therapeutic use; D003596:Cytosine / Q000031:analogs & derivatives / Q000191:economics / Q000494:pharmacology / Q000627:therapeutic use; D003715:Dengue / Q000188:drug therapy; D017277:Drug Approval; D015195:Drug Design; D000069347:Erlotinib Hydrochloride; D019142:Hemorrhagic Fever, Ebola / Q000188:drug therapy; D006801:Humans; D000068877:Imatinib Mesylate; D007211:Indoles / Q000191:economics / Q000494:pharmacology / Q000627:therapeutic use; D063065:Organophosphonates / Q000191:economics / Q000494:pharmacology / Q000627:therapeutic use; D010879:Piperazines / Q000191:economics / Q000494:pharmacology / Q000627:therapeutic use; D011684:Purine Nucleosides / Q000191:economics / Q000494:pharmacology / Q000627:therapeutic use; D011743:Pyrimidines / Q000191:economics / Q000494:pharmacology / Q000627:therapeutic use; D011758:Pyrroles / Q000191:economics / Q000494:pharmacology / Q000627:therapeutic use; D011759:Pyrrolidines; D011799:Quinazolines / Q000191:economics / Q000494:pharmacology / Q000627:therapeutic use; D000077210:Sunitinib; D014780:Viruses / Q000187:drug effects*
chemical_list: D000998:Antiviral Agents; D001549:Benzamides; D003524:Cyclosporins; D007211:Indoles; D063065:Organophosphonates; D010879:Piperazines; D011684:Purine Nucleosides; D011743:Pyrimidines; D011758:Pyrroles; D011759:Pyrrolidines; D011799:Quinazolines; C525733:brincidofovir; D002738:Chloroquine; D000068877:Imatinib Mesylate; D003596:Cytosine; D000069347:Erlotinib Hydrochloride; D000225:Adenine; D000241:Adenosine; C517546:galidesivir; D000077210:Sunitinib; C544142:SCY-635